PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

GPC%20Investor%20Presentation%20May%202018 - Genuine Parts Co | Presentation Nation

HomepageGenuine Parts CoGPC%20Investor%20Presentation%20May%202018

GPC%20Investor%20Presentation%20May%202018

Genuine Parts Co

Browse presentations, reports, and documents from Genuine Parts Co.

Tags

2020

Filter options

All (68)●
brochure (5)○
presentation (62)○
report (1)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

GPC%20Investor%20Presentation%20May%202018 by Genuine Parts Co.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Genuine Parts Co

2021%20March%20Investor%20Presentation

presentation

2023+Fact+Sheet

brochure

Similar presentations from other companies

Starboard-Value-Huntsman-Industrial-Starboard-Huntsman-Presentation-Mar-2022

presentation

Starboard Value

WABAG_11022022204956_SE_Intimation_Inv_Presentation_Q3FY2021_22

presentation

VA Tech Wabag

Genuine Parts Company_April_2021_299_68299

brochure

Genuine Parts Company_April_2022_794_81794

presentation

Genuine Parts Company_August_2020_343_60343

presentation

Genuine Parts Company_December_2021_615_77615

presentation

Reneo Pharmaceuticals_September_2021_672_74672

presentation

Reneo Pharmaceuticals

Trivago_August_2017_569_13569

presentation

Trivago

Dun & Bradstreet Holdings_November_2022_741_88741

presentation

Dun & Bradstreet

Ryvu-Therapeutics_Corporate-Presentation_November-2022-1

presentation

Ryvu Therapeutics